Related Experiment Video

Updated: Jun 14, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K

Reply to the Letter to the editor "Does axillary lymph node recurrence breast cancer subtype information matter for

Hirohito Seki1, Shinsuke Sasada2, Tadahiko Shien3

  • 1Department of Breast Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-City, Tokyo, 181-8611, Japan. hirohito.seki@gmail.com.

Breast Cancer (Tokyo, Japan)
|September 1, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

1.8K
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

11.9K

Related Experiment Videos

Last Updated: Jun 14, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

1.8K
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

11.9K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

Articles linked to this work by shared authors, journal, and citation graph.

Leveraging endocrine sensitivity in ER-positive DCIS: Neoadjuvant therapy and nonoperative management.

Breast (Edinburgh, Scotland)·2026

De-escalation of perioperative systemic therapy for early breast cancer.

Japanese journal of clinical oncology·2026

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

BJS open·2026

Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial.

Scientific reports·2026

Incidence and impact of odontogenic infection-related febrile episodes during perioperative doxorubicin-cyclophosphamide or docetaxel-cyclophosphamide chemotherapy for breast cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

De-escalation of breast surgery for early stage breast cancer.

Japanese journal of clinical oncology·2026

Association between preoperative body composition and health-related quality of life in breast cancer patients: a prospective Eastern European study.

Breast cancer (Tokyo, Japan)·2026

Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor-positive, HER2-negative metastatic breast cancer.

Breast cancer (Tokyo, Japan)·2026

The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer.

Breast cancer (Tokyo, Japan)·2026

Hormonal contraceptives and cancer risk in women with a BRCA1 or BRCA2 pathogenic variant.

Breast cancer (Tokyo, Japan)·2026

Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.

Breast cancer (Tokyo, Japan)·2026

Cost-effectiveness of mammography-based breast cancer screening in Jordan: a healthcare system perspective.

Breast cancer (Tokyo, Japan)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us